EichorEICHOR
Study identifier: NCT07467993 Synced from ClinicalTrials.gov · August 03, 2026
● Recruiting

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

Condition: Schizophrenia  ·  Sponsor: Novartis Pharmaceuticals

PhasePhase 2
Planned participants142
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The purpose of this study is to assess the efficacy, safety, and tolerability of GXV813 in the treatment of an acute episode of schizophrenia

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals  ·  1-888-669-6682  ·  novartis.email@novartis.com

Novartis Pharmaceuticals  ·  +41613241111

Always discuss trial participation with your own doctor first.

Locations (16)

Pillar Clinical Research LLCBentonville, Arkansas, United StatesRecruiting
CNRI Los Angeles LLCPico Rivera, California, United StatesRecruiting
Segal Institute for Clinical ResearchMiami, Florida, United StatesRecruiting
CenExel iResearchDecatur, Georgia, United StatesRecruiting
Uptown Research Institute LLCChicago, Illinois, United StatesRecruiting
Pillar Clinical Research LLCChicago, Illinois, United StatesRecruiting
Arch Clinical Trials LLCSt Louis, Missouri, United StatesRecruiting
Novartis Investigative SiteSofia, BGR, BulgariaRecruiting
Novartis Investigative SiteHaskovo, BulgariaRecruiting
Novartis Investigative SiteKazanlak, BulgariaRecruiting
Novartis Investigative SiteLovech, BulgariaRecruiting
Novartis Investigative SitePlovdiv, BulgariaRecruiting

+ 4 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07467993